Last edition
News about "Piramal Pharma subsidiary"
Piramal Pharma Acquires 40.67 Percent Additional Stake in Yapan Bio for INR 76 Crore
Piramal Pharma acquires an additional 40.67 percent stake in Yapan Bio for INR 76 crore, raising its ownership to 74 percent and expanding its biologics Contract Development and Manufacturing Organisation (CDMO) capabilities.
Piramal Pharma Subsidiary | 18/08/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members